COMMUNIQUÉS West-GlobeNewswire

Dyne Therapeutics Announces New Long-Term Clinical Data from Phase 1/2 DELIVER Trial of DYNE-251 in Duchenne Muscular Dystrophy Demonstrating Unprecedented and Sustained Functional Improvement Through 18 Months
17/03/2025
- Continued favorable safety profile for DYNE-251 - - DELIVER Registrational Expansion Cohort is fully enrolled; data from this cohort planned for late 2025 - - Potential for Biologics License Application submission for [...]
DentPure Under Review: How Probiotics Help Support Stronger Teeth & Healthier Gums
16/03/2025
Harnessing the Power of Probiotics to Combat Bad Breath, Strengthen Enamel, and Support Optimal Oral Health AURORA, Colo., March 16, 2025 (GLOBE NEWSWIRE) -- In an era where oral care is evolving beyond traditional [...]
Sutro Biopharma Presents Data from Dose-Optimization Portion of REFRαME-O1 Trial in Patients with Platinum Resistant Ovarian Cancer at SGO 2025
15/03/2025
- The late-breaking oral presentation at SGO 2025 highlights consistent response rates observed in patients across all levels of FRα expression of 25% or greater - SOUTH SAN FRANCISCO, Calif., March 15, 2025 (GLOBE [...]
Zentalis Pharmaceuticals Presents Updated Clinical Data at the Society of Gynecologic Oncology 2025 Annual Meeting on Women’s Cancer
15/03/2025
Azenosertib median duration of response (mDOR) updated to 6.3 months in the ongoing DENALI Part 1b clinical trial in patients with platinum-resistant ovarian cancer (PROC) and continues to demonstrate an objective [...]
ProDentim Under Review: Why Taking Probiotics for Stronger Teeth & Healthier Gums is Trending
15/03/2025
How Probiotics Are Transforming Dental Health and Redefining Oral Hygiene TALLMADGE, Ohio, March 15, 2025 (GLOBE NEWSWIRE) -- In 2025, the landscape of oral health is transforming, and at the forefront of this change is [...]
Cannabix Technologies announces Stock Option Grant and Director Resignation
14/03/2025
VANCOUVER, British Columbia, March 14, 2025 (GLOBE NEWSWIRE) -- Cannabix Technologies Inc. (CSE: BLO) (OTC PINK: BLOZF) (Frankfurt: 8CT) (the “Company or Cannabix”) reports it is granting 3,375,000 incentive stock [...]
Oculis Publishes Notifications of Transactions by Persons Discharging Managerial Responsibilities
14/03/2025
ZUG, Switzerland, March 14, 2025 (GLOBE NEWSWIRE) -- The attached notifications relate to annual equity incentive awards granted to members of the executive committee of the Company, as well as purchase of ordinary [...]
Arch Biopartners Closes Non-Brokered Private Placement
14/03/2025
TORONTO, March 14, 2025 (GLOBE NEWSWIRE) -- Arch Biopartners Inc. (“Arch” or the “Company”) (TSX Venture: ARCH and OTCQB: ACHFF) today announced it has closed a non-brokered private placement offering of 145,000 common [...]
Trinity Biotech Receives Non-Compliance Notice Regarding Nasdaq Global Select Requirement for Minimum Market Value of Publicly Held Shares and Nasdaq Minimum Bid Price Requirement
14/03/2025
DUBLIN, March 14, 2025 (GLOBE NEWSWIRE) -- Trinity Biotech plc (Nasdaq: TRIB), a commercial-stage biotechnology company focused on human diagnostics and diabetes management solutions, including wearable biosensors, [...]
Pacira BioSciences Confirms Receipt of Director Nominations from DOMA Perpetual
14/03/2025
-- No Shareholder Action Required at This Time -- PARSIPPANY, N.J., March 14, 2025 (GLOBE NEWSWIRE) -- Pacira BioSciences, Inc. (Nasdaq: PCRX), the industry leader in its commitment to deliver innovative, non-opioid [...]
Kestra Medical Technologies, Ltd. Announces Full Exercise and Closing of Underwriters' Over-Allotment Option in Initial Public Offering
14/03/2025
KIRKLAND, Wash., March 14, 2025 (GLOBE NEWSWIRE) -- Kestra Medical Technologies, Ltd. (“Kestra”), a wearable medical device and digital healthcare company, announced today that the underwriters of Kestra’s initial [...]
ExoPTEN Preclinical Study Demonstrates Significant Potential for Enhancing Motor Function, Blood Flow, and Spinal Cord Injury Recovery
14/03/2025
TORONTO and HAIFA, Israel, March 14, 2025 (GLOBE NEWSWIRE) -- NurExone Biologic Inc. (TSXV: NRX) (OTCQB: NRXBF) (FSE: J90) (“ NurExone ” or the “ Company ”) is pleased to announce that it has successfully completed an [...]
Nurix Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
14/03/2025
SAN FRANCISCO, March 14, 2025 (GLOBE NEWSWIRE) -- Nurix Therapeutics, Inc. (Nasdaq: NRIX), a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of targeted protein [...]
Fifty 1 Labs, Inc. Completes Name and Symbol Change, Advances Toward Regaining 15c211 Compliance
14/03/2025
MELBOURNE, Fla., March 14, 2025 (GLOBE NEWSWIRE) -- via IBN -- Fifty 1 Labs, Inc. ( OTCPK: FITY ), formerly Consumer Automotive Finance, Inc. (OTCPK: CAFI), a dynamic leader in the sports supplement, fitness equipment, [...]
Blue Antioxidant: How Prime Biome Restores Skin with 10x Retinol Strength
14/03/2025
ST. PETERSBURG, Fla., March 14, 2025 (GLOBE NEWSWIRE) -- Prime Biome is a holistic daily supplement whose Blue Antioxidant is touted to be up to ten times stronger than standard retinol. For decades, retinol has [...]
Notice to Convene Annual General Meeting 2025 - Item 6: Election of members to the Board of Directors
14/03/2025
Company announcement no. 4– 25 14 March 2025 Notice to Convene Annual General Meeting 2025 - Item 6: Election of members to the Board of Directors Following the publication of the Notice to Convene the Annual General [...]
Orion Corporation: Disclosure Under Chapter 9 Section 10 of the Securities Market Act (BlackRock, Inc.)
14/03/2025
ORION CORPORATION STOCK EXCHANGE RELEASE / MAJOR SHAREHOLDER ANNOUNCEMENTS 14 MARCH 2025 at 15.30 EET Orion Corporation: Disclosure Under Chapter 9 Section 10 of the Securities Market Act (BlackRock, Inc.) Orion [...]
Healthcare Integrated Technologies Inc. Successfully Raises $10 million in Friends & Family Funding
14/03/2025
Knoxville, TN, March 14, 2025 (GLOBE NEWSWIRE) -- Healthcare Integrated Technologies Inc. (OTC PINK: HITC), a global leader in AI-driven safety and monitoring solutions, proudly announces the successful completion of a [...]
Polyrizon Signs Non– Binding LOI to Expand its Innovative Intranasal Drug Delivery Platform for Psychedelic-Based Treatments
14/03/2025
Raanana, Israel, March 14, 2025 (GLOBE NEWSWIRE) -- Polyrizon Ltd. (Nasdaq: PLRZ) (the “Company” or “Polyrizon”), a development stage biotech company specializing in the development of innovative intranasal hydrogels, [...]

Pages